Sun Pharmaceutical Industries Q3 FY24 consolidated PAT up at Rs. 2,560.54 Cr

Sun Pharmaceutical Industries Q3 FY24 consolidated PAT up at Rs. 2,560.54 Cr

By: IPP Bureau

Last updated : February 01, 2024 11:48 am



Sun Pharmaceutical Industries has reported total income of Rs. 12,630.9 crores during the period ended December 31, 2023


Sun Pharmaceutical Industries Limited has reported consolidated financial results for the period ended December 31, 2023.

Sun Pharmaceutical Industries has posted net profit of Rs. 2,560.54 crores for the period ended December 31, 2023 as against net profit of Rs. 2,385.1 crores for the period ended September 30, 2023. The company posted net profit of Rs.2, 180.75 crores for the period ended December 31, 2022.

Sun Pharmaceutical Industries has reported total income of Rs. 12,630.9 crores during the period ended December 31, 2023 as compared to Rs. 12,486.02 crores during the period ended September 30, 2023. The company reported total income of Rs.11, 414.85 crores during the period ended December 31, 2022.

For the 9 months period ended December 31, 2023, Sun Pharmaceutical Industries has reported total income of Rs.37, 262.2 crores as compared to Rs.33, 216.25 crores during the 9 months period ended December 31, 2022.

The company has posted net profit of Rs.6, 951.29 crores for the 9 Months period ended December 31, 2023 as against net profit of Rs.6, 530.04 crores for the 9 Months period ended December 31, 2022.

Sun Pharmaceutical Industries

First Published : February 01, 2024 12:00 am